Misinformation On OTC EC Limits Use By Adolescents – Study
This article was originally published in The Tan Sheet
Adolescents routinely receive misinformation about the availability of nonprescription access to emergency contraception, researchers report in Pediatrics. The study shows FDA’s current regulatory scheme isn’t providing access to 17-year-olds, one author says.
You may also be interested in...
HHS Secretary Sebelius says Teva must show more evidence of how young adolescent females would use Plan B One-Step as an OTC. But obtaining such clinical data for the emergency contraceptive – in excess of what FDA already needed to approve it – appears nearly impossible, experts say.
The Health Choices Coalition sent letters urging House and Senate members to support legislation that would strike the health care reform law requirement that consumers obtain a prescription in order to purchase OTCs with a pre-tax savings account.
Homeopathic firm TheraBiogen plans to roll out products “every six to nine months” to add to its existing lineup of homeopathic remedies for allergy and cold and flu, says CEO Kelly Hickel. The firm also counts on sales growth from a social media campaign to explain what is not in its products as well as what is.